Friday, December 23, 2011

Biochemical Test Could Diagnose Alzheimer’s

Please Help Support Alzheimer's Research Today! 
Your Alzheimer's donation will help billions live without it.

(Years in Advance)
Afflicting millions of patients, Alzheimer’s disease is becoming a growing burden to healthcare systems around the world. The condition is typically diagnosed after symptoms of mild cognitive impairment arise. Not all patients with mild cognitive impairment, however, develop Alzheimer’s. To understand what sets Alzheimer’s patients apart, scientists at the VTT Technical Research Centre (Espoo, Finland) set out to use biomarkers to look at the molecular changes behind the disease.
The new research indicates that a biochemical assay from a serum sample could be used to predict Alzheimer’s disease months or years before symptoms begin to take a toll on a patient. Professor Matej Orešič from the VTT Technical Research Centre believes that the disease is preceded by a molecular signature indicating potential involvement of hypoxia and an up-regulated pentose phosphate pathway. Continue to read: medgadget.com


Folic acid plus B12 shows brain function benefits in older people

Long term supplementation of folic acid and vitamin B12 may promote improvements in brain functioning in older people, according to new research. Read more: nutraingredients.com
Get Energy Active!
Погода в Беларуси


Posted YVN (AMYLOID @ PHOTO). 
at

No comments:

Post a Comment